Authors:
Kruszynski, R
Bartczak, TJ
Chilmonczyk, Z
Cybulski, J
Citation: R. Kruszynski et al., 4-[3-(4-fluorobenzylideneamino)-2-oxo-1,3-oxazolidin-5-ylmethyl]morpholin-4-ium chloride monohydrate, ACT CRYST E, 57, 2001, pp. O469-O471
Authors:
Bartczak, TJ
Kruszynski, R
Chilmonczyk, Z
Cybulski, J
Citation: Tj. Bartczak et al., 4-[3-(4-chlorobenzylideneamino)-2-oxooxazolidin-5-ylmethyl]morpholin-4-iumchloride monohydrate, ACT CRYST E, 57, 2001, pp. o341-o343
Authors:
Poplawski, J
Lozowicka, B
Dubis, AT
Lachowska, B
Wikowski, S
Siluk, D
Petrusewicz, J
Kaliszan, R
Cybulski, J
Strzalkowska, M
Chilmonczyk, Z
Citation: J. Poplawski et al., Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo), J MED CHEM, 43(20), 2000, pp. 3671-3676
Authors:
Szelejelska-Wozniakowska, A
Chilmonczyk, Z
Les, A
Cybulski, J
Wawer, I
Citation: A. Szelejelska-wozniakowska et al., C-13 cross-polarization magic angle spinning NMR and gauge-independent atomic orbital, coupled Hartree-Fock calculations of buspirone analogues Part 2. Hydrochlorides and perchlorates of 1-arylpiperazine-4-alkylimides, SOL ST NUCL, 14(1), 1999, pp. 59-65